Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Zogenix, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| Zogenix, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| Zogenix, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| Zogenix, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 9 | 1 |
| Zogenix, Inc., Medical Devices Deals, 2010 to YTD 2016 | 10 | 1 |
| Zogenix, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 11 | 2 |
| Zogenix, Inc., Pharmaceuticals &Healthcare, Deal Details | 13 | 36 |
| Venture Financing | 13 | 1 |
| Zogenix Secures US$15 Million In Venture Financing | 13 | 2 |
| Partnerships | 15 | 1 |
| Mallinckrodt Pharma And Zogenix Terminates Co-Promotion Agreement For Sumavel DosePro | 15 | 1 |
| Zogenix And Battelle Memorial Institute Extend Co-Marketing Agreement For DosePro | 16 | 1 |
| Zogenix Enters Into Co-Promotion Agreement With Valeant Pharma For Migranal Nasal Spray | 17 | 2 |
| Zogenix And Battelle Memorial Institute Extend Co-Marketing Agreement For DosePro | 19 | 1 |
| Zogenix Enters Into Co-Promotion Agreement With Mallinckrodt For Sumavel DosePro | 20 | 1 |
| Zogenix Enters Into Co-Marketing Agreement With Battelle Memorial Institute For DosePro | 21 | 2 |
| Zogenix Terminates Co-Promotion Agreement With Astellas Pharma US For Sumavel DosePro | 23 | 1 |
| Licensing Agreements | 24 | 1 |
| Zogenix Amends Licensing Agreement with Daravita | 24 | 1 |
| Zogenix Enters Into Licensing Agreement With Altus Formulation For Zohydro ER | 25 | 1 |
| Zogenix Amends Agreement with Elan Pharma | 26 | 1 |
| Zogenix Enters Into Licensing Agreement With DURECT | 27 | 2 |
| Equity Offering | 29 | 1 |
| Zogenix Raises USD98.3 Million in Public Offering of Shares | 29 | 2 |
| Zogenix Completes Public Offering Of Shares For US$69 Million | 31 | 2 |
| Zogenix Announces Public Offering Of Shares For Up To US$25 Million | 33 | 1 |
| Zogenix Completes Public Offering Of Units For US$70 Million | 34 | 2 |
| Zogenix Completes Public Offering Of Common Stock For US$61.4 Million | 36 | 2 |
| Zogenix Completes Private Placement Of Common Stock For US$1.5 Million | 38 | 1 |
| Zogenix Completes IPO For US$57.7 Million | 39 | 2 |
| Asset Transactions | 41 | 1 |
| Pernix Acquires Zohydro ER Business from Zogenix | 41 | 2 |
| Endo International Completes Acquisition of Sumavel DosePro Migraine Therapy Business from Zogenix | 43 | 2 |
| Cowen Healthcare Royalty Partners Acquires Royalties Of SUMAVEL DosePro And Zohydro From Zogenix | 45 | 2 |
| Acquisition | 47 | 1 |
| Zogenix Acquires Brabant Pharma for USD130 Million | 47 | 2 |
| Zogenix, Inc. - Key Competitors | 49 | 1 |
| Key Employees | 50 | 1 |
| Locations And Subsidiaries | 51 | 1 |
| Head Office | 51 | 1 |
| Other Locations &Subsidiaries | 51 | 1 |
| Appendix | 52 | 1 |
| Methodology | 52 | 1 |
| About GlobalData | 52 | 1 |
| Contact Us | 52 | 1 |
| Disclaimer | 52 | 1 |